Ventyx Biosciences, Inc.
Status: Publicly traded
Direct answer
Ventyx Biosciences, Inc. is publicly traded on NASDAQ under the ticker VTYX.
Ventyx Biosciences, Inc. is a biopharmaceutical company in the clinical development phase, specializing in the creation of small molecule therapeutics for inflammatory and autoimmune disorders. The company's primary investigational drug, VTX958, a tyrosine kinase type 2 (TYK2) inhibitor, is currently undergoing Phase I clinical trials. This compound aims to address a range of immune-mediated conditions, including...
Can you invest in Ventyx Biosciences, Inc.?
Yes. Ventyx Biosciences, Inc. trades publicly on NASDAQ as VTYX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ventyx Biosciences, Inc.
Detailed equity research is provided by MarketSnap.